(Q57044074)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

Pathogenesis, prediction and trials for the prevention of insulin-dependent (type 1) diabetes mellitus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

2

Eisenbarth GS

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

English

0 references

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

Advanced Drug Delivery Reviews

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

143-156

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Type I diabetes mellitus. A chronic autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Long-term risk of IDDM in first-degree relatives of patients with IDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Panning for gold: genome-wide scanning for linkage in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

A genome-wide search for human type 1 diabetes susceptibility genes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

The genetic susceptibility to type 1 (insulin-dependent) diabetes: analysis of the HLA-DR association

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Contribution of DRB1*04 Variants to Predisposition to or Protection from Insulin Dependent Diabetes Mellitus is Independent of DQ

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Susceptibility to type I diabetes: HLA-DQ and DR revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Prevention of type I diabetes in nonobese diabetic mice by virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

The Swedish childhood diabetes study--social and perinatal determinants for diabetes in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Early infection and subsequent insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

RELATION BETWEEN BREAST-FEEDING AND INCIDENCE RATES OF INSULIN-DEPENDENT DIABETES MELLITUS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

A Bovine Albumin Peptide as a Possible Trigger of Insulin-Dependent Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

A meta-analysis of infant diet and insulin-dependent diabetes mellitus: do biases play a role?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

The role of enteroviral infections in the development of IDDM: limitations of current approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Sequence homology of the diabetes-associated autoantigen glutamate decarboxylase with coxsackie B4-2C protein and heat shock protein 60 mediates no molecular mimicry of autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Coxsackie B virus infection and onset of childhood diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of type I diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Coxsackie B virus IgM in children at onset of type 1 (insulin-dependent) diabetes mellitus: evidence for IgM induction by a recent or current infection

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Serologic evidence of an association between enteroviruses and the onset of type 1 diabetes mellitus. Pittsburgh Diabetes Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

A case-control study of group B Coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children--no evidence of increased antibody frequency

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Indications that maternal coxsackie B virus infection during pregnancy is a risk factor for childhood-onset IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Coxsackie-B-virus-specific IgM responses, complement-fixing islet-cell antibodies, HLA DR antigens, and C-peptide secretion in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Matching of host genotype and serotypes of Coxsackie B virus in the development of juvenile diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Mouse or man. Is GAD the cause of type I diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9-23)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Antigen based therapies to prevent diabetes in NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Nicotinamide--biological actions and therapeutic potential in diabetes prevention. IDIG Workshop, Copenhagen, Denmark, 4-5 December 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

A population based strategy to prevent insulin-dependent diabetes using nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Prevention or delay of Type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Metabolically inactive insulin analog prevents type I diabetes in prediabetic NOD mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Oral insulin treatment suppresses virus-induced antigen-specific destruction of beta cells and prevents autoimmune diabetes in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Administering glutamic acid decarboxylase to NOD mice prevents diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Immunization therapies in the prevention of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Islet autoantibody markers in IDDM: risk assessment strategies yielding high sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Insulin prophylaxis in individuals at high risk of type I diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Prevention of type I diabetes and recurrent beta-cell destruction of transplanted islets

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

Prophylactic insulin treatment in relatives at high risk for type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2898%2900070-2

7 January 2021

10.1016/S0169-409X(98)00070-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10837695%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference